MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
ARS Pharmaceuticals, Inc. Common Stock

SPRY

#2141
ARS Pharmaceuticals, Inc. Common Stock
9.2970
-1.62%
Sector:
Base:
Profit Currency:
Daily Range
9.2800
9.2970
Year Range
6.6600
13.1500
Daily Change
-1.62%
Monthly Change
-11.46%
6 month change
+0.94%
Year Change
+0.94%
Previous Close
9.4500
Open
9.2800
Bid
Ask
Low
9.2800
High
9.2970
Volume
101
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. SPRY
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Seeking Alpha Seeking Alpha
SPRY
2026.02.14
ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)
Benzinga Benzinga
SPRY AQST
2026.01.09
What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)
Benzinga Benzinga
AQST SPRY
2026.01.09
Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)
Investing Investing
SPRY
2025.12.29
China approves first community use epinephrine nasal spray for allergies
Investing Investing
SPRY
2025.11.14
ARS Pharma CBO Chakma sells shares worth $1.47 million
Investing Investing
SPRY
2025.11.14
Dorsey, ARS Pharma COO, sells $190k in SPRY stock
Seeking Alpha Seeking Alpha
SPRY
2025.11.10
ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript
Investing Investing
SPRY
2025.11.10
ARS Pharmaceuticals stock reaffirmed Outperform by William Blair on neffy data
Investing Investing
SPRY
2025.11.10
ARS Pharmaceuticals stock rises on strong Q3 sales, Raymond James reiterates Strong Buy
Zacks Zacks
SPRY VVOS
2025.11.10
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates
Investing Investing
SPRY
2025.11.10
ARS Pharmaceuticals earnings missed by $0.06, revenue topped estimates
Zacks Zacks
LPCN SPRY
2025.11.06
Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd